Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 26.03.2024
AQUEDUCT EUROPEAN CLO 8 DESIGNATED ACTIVITY COMPANY
COMPANY ANNOUNCEMENT
25 March 2024
AQUEDUCT EUROPEAN CLO 8 DESIGNATED ACTIVITY COMPANY (formerly Aqueduct European CLO 9-2022 DAC)
(a designated activity company incorporated under the laws of Ireland with registered number 707371 and having its registered office in Ireland) (the “Borrower”)
ISIN: IE000Q3CBH59
For immediate release
We hereb [ … ]
Tue, 26.03.2024
MBB SE
MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024
Berlin, 26 March 2024 - MBB SE (ISIN DE000A0ETBQ4), a medium-sized family business, grew its revenues by 6.5% to €954.6 million in the 2023 financial year. The Group's adjusted EBITDA reached €80.2 million, compared to €93.2 million in the previous year. While the Ser [ … ]
Tue, 26.03.2024
JOST Werke SE
JOST closes fiscal year 2023 successfully and proposes a dividend of EUR 1.50 per share
JOST confirms preliminary results: Financial targets achieved in fiscal year 2023
Stable sales in 2023: Sales at EUR 1,250 million (2022: EUR 1,265 million)
Profitability significantly improved: Adjusted EBIT increases by 14% to EUR 141 million (2022: EUR 12 [ … ]
Tue, 26.03.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC OTCQB: DTCFF PRESS RELEASE
DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE
Vancouver, BC, Canada, March 26th, 2024 - Defence Therapeutics Inc. (“Defence” or [ … ]
Tue, 26.03.2024
CHAPTERS Group AG
In May 2023, the company placed the bearer bonds held by the company itself from the 2020 bond (ISIN: DE000A254TL0) and committed to an anchor investor to conduct one or more public buyback offers if certain conditions are met. In the meantime, the company has received funds from the repayment of shareholder loans issued in previous years. The Mana [ … ]
Tue, 26.03.2024
Viscom AG
Viscom AG closes 2023 financial year in line with forecast; very subdued start to 2024 financial year
Incoming orders: € 113,248 thousand (previous year: € 111,065 thousand, +2.0 %)
Revenue: € 118,780 thousand (previous year: € 105,518 thousand, +12.6 %)
EBIT: € 6,611 thousand (previous year: € 8,186 thousand, -19.2 %)
EBIT-Margin: 5.6 % (previ [ … ]
Tue, 26.03.2024
Marinomed Biotech AG
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
Gulf-region specialist GAIA Healthcare FZ LLC obtains license for the marketing of Carragelose nasal sprays
Expansion of Carragelose partner network in Eastern Europe with VitaPlus Kft.
Korneuburg, Austria, 26 March 2024 – Marinomed Biotech AG [ … ]
Tue, 26.03.2024
Marinomed Biotech AG
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
Gulf-region specialist GAIA Healthcare FZ LLC obtains license for the marketing of Carragelose nasal sprays
Expansion of Carragelose partner network in Eastern Europe with VitaPlus Kft.
Korneuburg, Austria, 26 March 2024 – Marinomed Biotech AG [ … ]
Tue, 26.03.2024
Friedrich Vorwerk Group SE
FRIEDRICH VORWERK generates revenues of €373 million in 2023 with an EBITDA margin of 8.6% and expects further sales and earnings growth in 2024 with an order backlog of €1 billion
Tostedt, March 26, 2024 - FRIEDRICH VORWERK Group SE (ISIN DE000A255F11), a leading provider of energy infrastructure solutions for gas, electricity and hydrogen applic [ … ]
Tue, 26.03.2024
Aumann AG
Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity
Beelen, 26 March 2024
Aumann AG ("Aumann", ISIN: DE000A2DAM03), a leading manufacturer of automation solutions for electromobility, successfully continued its profitable growth trajectory in the 2023 financial year. Aumann's [ … ]